Signature substrate mutations associated with HIV-1 protease inhibitor resistance

被引：0

作者：

Kolli, M. ^{[1
]}

Stawiski, E. ^{[2
]}

Chappey, C. ^{[2
]}

Parkin, N. ^{[2
]}

Schiffer, C. A. ^{[1
]}

机构：

[1] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA

[2] Monogram Biosci Inc, San Francisco, CA USA

来源：

ANTIVIRAL THERAPY | 2007年 / 12卷

关键词：

D O I：

暂无

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：S144 / S144

页数：1

共 50 条

[41] Resistance to HIV-1 protease inhibitors [J].

Swanstrom, R ;

Smith, T .

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 213 :58-BIOT

[42] Increasing prevalence of HIV-1 protease inhibitor-associated mutations correlates with long-term non-suppressive protease inhibitor treatment [J].

Kagan, R. M. ;

Cheung, P. K. ;

Huard, T. K. ;

Lewinski, M. A. .

ANTIVIRAL RESEARCH, 2006, 71 (01) :42-52

[43] Mechanism of substrate binding to HIV-1 protease [J].

Toth, G ;

Borics, A ;

Meshkat, S .

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 :U799-U799

[44] Predicting substrate specificity in HIV-1 protease [J].

Ozer, N ;

Schiffer, CA ;

Haliloglu, T .

PROTEIN SCIENCE, 2004, 13 :193-194

[45] Analyses of accessory mutations in HIV-1 protease reveal interdependent mechanisms of resistance [J].

Ragland, D. A. ;

Nalam, M. N. L. ;

Ozen, A. ;

Cai, Y. ;

Cao, H. ;

Schiffer, C. A. .

ANTIVIRAL THERAPY, 2014, 19 :A155-A155

[46] Accessory mutations balance the marginal stability of the HIV-1 protease in drug resistance [J].

Weikl, Thomas R. ;

Hemmateenejad, Bahram .

PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2020, 88 (03) :476-484

[47] HIV-1 protease inhibitors and mechanisms of HIV-1's resistance [J].

Das, Debananda .

GLOBAL HEALTH & MEDICINE, 2024, 6 (06) :357-362

[48] Implications of substrate shape on inhibitor binding and drug resistance: the crystal structure of RO1 in complex with HIV-1 protease [J].

Prabu-Jeyabalan, M ;

King, N ;

Nalivaika, E ;

Heilek-Snyder, G ;

Cammack, N ;

Schiffer, C .

ANTIVIRAL THERAPY, 2005, 10 (04) :S85-S85

[49] Implications of substrate shape on inhibitor binding and drug resistance: the crystal structure of RO1 in complex with HIV-1 protease [J].

Prabu-Jeyabalan, M ;

King, N ;

Nalivaika, E ;

Heilek-Snyder, G ;

Cammack, N ;

Schiffer, C .

ANTIVIRAL THERAPY, 2005, 10 :S85-S85

[50] Optimization of a macromolecular inhibitor of HIV-1 protease [J].

Dauber, DS ;

McPhee, F ;

Ünal, A ;

Craik, CS .

ASPARTIC PROTEINASES: RETROVIRAL AND CELLULAR ENZYMES, 1998, 436 :65-70

← 1 2 3 4 5 →